NCT06753227View on ClinicalTrials.gov

Invasive Versus Echocardiography-derived Transvalvular Gradients After TAVI Usign Balloon-expandable Transcatheter Heart Valves.

Enrolling by invitationOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
AORTIC VALVE DISEASESAortic Stenosis
Trial Locations (1)

80636

Deutsches Herzzentrum München, Munich

Sponsors

Collaborators (1)

Edwards Lifesciences
All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Deutsches Herzzentrum Muenchen

OTHER